CytoChip
Irvine · Founded 2016
About CytoChip
Our journey began with a research project to develop a portable blood cell testing device for astronauts on space missions. Today, we are bringing that cutting-edge technology down to Earth to transform point-of-care diagnostics, from hospitals and clinics to pharmacies and home care. After nine years of development, CytoChip’s first product, CitoCBC®, is ready for launch. Using just one drop of blood, CitoCBC® delivers lab-quality CBC results within minutes, offering accuracy comparable to central laboratory analyzers at the point of care. At our core, we are a team of passionate engineers and scientists spanning two continents, united by a singular goal: to make reliable, affordable diagnostics accessible to more people worldwide. Our headquarters and R&D centerare located in California, USA, while our engineering and manufacturing center is based in Suzhou, China. We collaborate closely with leading U.S. hospitals to advance clinical validation and innovation. Starting with the world’s first CLIA Waived cartridge-based CBC, we are committed to tackling the toughest innovation challenges in point-of-care testing. Our mission is to empower healthcare providers with reliable, cost-effective diagnostics and make data-driven testing more accessible to patients and consumers.
Company Facts
- Founded: 2016
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $12.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2021)
- Website: https://www.cytochipinc.com
- Phone: [email protected]
Industries & Categories
Health Diagnostics, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/cytochip-43168 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.